| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |